SCHEMBL6611275

SCHEMBL6611275

N#C/C=C(\Cl)c1ccc(C#N)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.45
CA1 P00915 2/20 0.45
CA12 O43570 1/20 0.43
CA3 P07451 1/20 0.43
CA6 P23280 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
GSK3B P49841 2/20 0.41
FBP1 P09467 1/20 0.40
MMP3 P08254 1/20 0.39
ENPP2 Q13822 1/20 0.39
ALDH1A1 P00352 4/20 0.38
CYP2A6 P11509 1/20 0.38
PARP15 Q460N3 1/20 0.38
PARP10 Q53GL7 1/20 0.38
PARP2 Q9UGN5 1/20 0.38
P4HB P07237 1/20 0.38
RECQL P46063 1/20 0.37
MAPT P10636 2/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5197081 1.00 CA2 (0.45) CA2CA1CA12CA3CA6
SCHEMBL5197078 1.00 CA2 (0.45) CA2CA1CA12CA3CA6
SCHEMBL18076909 0.81 CA2 (0.47) CA2CA1CA12CA3CA6
SCHEMBL5774267 0.81 TSHR (0.43) CA2CA1GSK3BALDH1A1CYP2A6
SCHEMBL6166570 0.81 CA2 (0.47) CA2CA1CA12CA3CA6
SCHEMBL28858577 0.81 CA2 (0.52) CA2CA1CA12CA3CA6
SCHEMBL28858579 0.81 CA2 (0.52) CA2CA1CA12CA3CA6
SCHEMBL5774264 0.81 TSHR (0.43) CA2CA1GSK3BALDH1A1CYP2A6
SCHEMBL4617683 0.79 MAPT (0.46) CA2CA1ALDH1A1RECQLMAPT
SCHEMBL4617688 0.79 MAPT (0.46) CA2CA1ALDH1A1RECQLMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444010-A2 HETEROAROMATIC CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2004-08-11 EP disclosed
WO-2003037886-A2 HETEROAROMATIC CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2003-05-08 WO disclosed